美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sienna Biopharmaceuticals Inc.

0.1358

0.0000

成交量：- -

成交額：- -

市值：417.79萬

市盈率：-0.08

高：0.1358

開：0.1358

低：0.1358

收：0.1358

52周最高：3.80

52周最低：0.0640

股本：3,076.49萬

流通股本：2,279.22萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.8000

每股收益(LYR):-3.5927

淨資產收益率：-140.97%

總資產收益率：-32.10%

市淨率：0.18

市盈率(LYR):-0.04

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Sienna Biopharmaceuticals Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.SiennaBio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Sienna Biopharmaceuticals, Inc.於2010年7月27日在特拉華州成立，名為Sienna Labs Inc.。在2016年2月，公司更名為Sienna Biopharmaceuticals，Inc.。該公司是一家臨床階段的生物製藥公司，專註於將生物技術的創新引入醫學皮膚病學和美學領域，發現，開發和商業化一流，有針對性的主題產品。他們的目標是發展他們的多資產管理的局部治療，增強皮膚病患者的健康，外觀和生活質量。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SNNA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SNNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNNA\",,,,,undefined,":{"symbol":"SNNA","market":"US","secType":"STK","nameCN":"Sienna Biopharmaceuticals Inc.","latestPrice":0.1358,"timestamp":1578690000000,"preClose":0.1358,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":22792154,"shares":30764904,"eps":-1.799979,"marketStatus":"未開盤","change":0,"latestTime":"01-10 16:00:00 EST","open":0.1358,"high":0.1358,"low":0.1358,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.799979,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1501128000000,"exchange":"NASDAQ","adjPreClose":0.1358,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNNA\",,,,,undefined,":{"symbol":"SNNA","floatShares":22792154,"roa":"-32.10%","roe":"-140.97%","lyrEps":-3.592713,"shares":30764904,"dividePrice":0,"high":0.1358,"amplitude":0,"preClose":0.1358,"low":0.1358,"week52Low":0.064,"pbRate":"0.18","week52High":3.8,"institutionHeld":0,"latestPrice":0.1358,"eps":-1.799979,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.799979,"open":0.1358,"prevYearClose":0.1358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-12","symbol":"SNNA","fiscalQuarterEnding":"2019/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"","actualEps":-0.16},{"market":"US","date":"2019-08-08","symbol":"SNNA","fiscalQuarterEnding":"2019/06","expectedEps":-0.43,"name":null,"time":"","type":"earning","dateTimestamp":1565236800000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2019-05-08","symbol":"SNNA","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"","actualEps":-0.67},{"market":"US","date":"2019-03-14","symbol":"SNNA","fiscalQuarterEnding":"2018/12","expectedEps":-0.83,"name":null,"time":"","type":"earning","dateTimestamp":1552536000000,"reportTimeType":"","actualEps":-0.93},{"market":"US","date":"2018-11-08","symbol":"SNNA","fiscalQuarterEnding":"2018/09","expectedEps":-0.79,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNNA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.SiennaBio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Sienna Biopharmaceuticals, Inc.於2010年7月27日在特拉華州成立，名為Sienna Labs Inc.。在2016年2月，公司更名為Sienna Biopharmaceuticals，Inc.。該公司是一家臨床階段的生物製藥公司，專註於將生物技術的創新引入醫學皮膚病學和美學領域，發現，開發和商業化一流，有針對性的主題產品。他們的目標是發展他們的多資產管理的局部治療，增強皮膚病患者的健康，外觀和生活質量。","exchange":"NASDAQ","name":"Sienna Biopharmaceuticals Inc.","nameEN":"Sienna Biopharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SNNA\",market:\"US\",,,undefined,":null}}